N1VO34:BVMF
Novo Nordisk Bdr
23,92 R$
0,00%
(0,00) 1D
13 ოქტ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for N1VO34...
Open
24,01 R$
High
24,36 R$
Low
23,80 R$
Mkt. cap
128,51 მლრ.
Avg. vol.
34,82 ათ.
Volume
8,45 ათ.
52-wk high
42,43 R$
52-wk low
22,90 R$
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
Open
24,01 R$
High
24,36 R$
Low
23,80 R$
Mkt. cap
128,51 მლრ.
Avg. vol.
34,82 ათ.
Volume
8,45 ათ.
52-wk high
42,43 R$
52-wk low
22,90 R$
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
News stories
From web sources and news partners
The Motley Fool
·
6 საათის წინ
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance
·
7 საათის წინ
Why Novo Nordisk (NVO) Dipped More Than Broader Market Today
Yahoo! Finance Canada
·
8 საათის წინ
Top Analyst Reports for Walmart, Visa & Novo Nordisk
TipRanks
·
17 საათის წინ
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk Bdr
CEOმაზიარ მაიკ დუსტარ
Employees66,7 ათ.
Founded1923
HeadquartersBagsværd, დედაქალაქის რეგიონი, დანია
SectorPharmaceutical industry
Websitenovonordisk.com